Oncology

HER2+ Breast Cancer

Expert Perspectives® in HER2+ Breast Cancer to Cover Key Topics in Breast Cancer Treatment

expert perspectives by Mothaffar F. Rimawi, MD, FACP; Hope S. Rugo, MD, FASCO; Paolo Tarantino, MD, PhD

Overview

Expert Perspectives^® delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. Expert Perspectives^® in HER2+ Breast Cancer will feature community-selected experts and topics that we hope you will find of value in your clinical practice.

VIEW THE TOPICS:

Expert Roundtables

Expert Roundtables Podcast: Redefining the HER2 Spectrum in Breast Cancer: Clinical Actionability of Low and Ultralow Status
Sequencing Anti-HER2 Therapies After ADC Progression in HER2+ Metastatic Breast Cancer

Clinical Topic Updates

Combination Strategies With HER2-Directed ADCs in HER2+ Breast Cancer
Next-Generation ADCs in HER2+ Breast Cancer: Emerging Agents, Targets, and Payloads
Recognizing and Managing ILD/Pneumonitis During ADC Therapy in HER2+ Breast Cancer

Patient Care Perspectives

Multidisciplinary Management of Complex Toxicities in HER2-Directed Therapy for HER2+ Breast Cancer
Navigating Treatment Choices and Changing Goals in HER2+ Breast Cancer
Patent Recognition and Reporting of ILD/Pneumonitis Symptoms During ADC Therapy for HER2+ Breast Cancer

Profile

Mothaffar F. Rimawi, MD, FACP

Professor of Medicine
Executive Medical Director
Associate Director for Clinical Affairs
Dan L Duncan Comprehensive Cancer Center
Philip A. Salem, M.D. Chair in Cancer Research
Baylor St. Luke’s Medical Center
Baylor College of Medicine
Houston, TX

Profile

Hope S. Rugo, MD, FASCO

Director, Women’s Cancers Program
Division Chief, Breast Medical Oncology
Professor, Department of Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, CA